Synalar-N
Synalar-N is a medicine authorised by Swissmedic under authorisation number 29729. The authorisation holder is FARMACEUTICA TEOFARMA SUISSE SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 June 1963 and the authorisation is valid without a time limit. ATC code D07CC02 places the medicine in the group Corticosteroids, dermatological preparations.
| Authorisation number | 29729 |
|---|---|
| Name | Synalar-N |
| Full name | Synalar-N, Creme |
| Authorisation holder | FARMACEUTICA TEOFARMA SUISSE SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | D07CC02 |
| First authorisation | 24 June 1963 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Synalar-N, Creme | B | 24 June 1963 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 26 | 15 | g | D07CC02 | 10.05.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Synalar-N authorised in Switzerland?
Yes. Synalar-N is authorised by Swissmedic under authorisation number 29729, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Synalar-N have?
Synalar-N is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Synalar-N?
The authorisation holder is FARMACEUTICA TEOFARMA SUISSE SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.